Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

General Medicine

Effects of Aspirin Therapy in Patients Hospitalized With COVID-19

Estie Mermelstein, MSN, FNP-BC

December 29, 2021

Investigators conducted a study to assess the efficacy and safety of aspirin therapy in patients hospitalized with COVID-19.

General Medicine

Outcomes of Positive Expiratory Pressure Flute Therapy in Adults With COVID-19

Estie Mermelstein, MSN, FNP-BC

December 28, 2021

Investigators conducted a study to determine whether positive expiratory pressure flute self-care decreases the risk for respiratory symptoms in adults recently diagnosed with SARS-CoV-2 infection.

General Medicine

Association Between Urine Biomarkers and Acute Kidney Injury in Patients With COVID-19

Estie Mermelstein, MSN, FNP-BC

December 7, 2021

Researchers conducted a study to determine whether molecular biomarkers of tubular injury measured on hospital admission are a significant predictor of acute kidney injury in patients with SARS-CoV-2 infection.

General Medicine

Efficacy, Safety, Tolerability of Investigational Oral COVID-19 Antiviral Candidate Paxlovid

Estie Mermelstein, MSN, FNP-BC

December 3, 2021

Researchers conducted a study to assess the clinical efficacy, safety, and tolerability of Paxlovid (PF-07321332/ritonavir), an oral SARS-CoV-2 Mpro inhibitor candidate for the treatment of COVID-19.

General Medicine

Early Treatment With Sotrovimab Decreases Risk for Progression to Severe COVID-19

Estie Mermelstein, MSN, FNP-BC

November 22, 2021

Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.

Doctor with radiological chest x-ray film for medical diagnosis

Tuberculosis

Optimal Dosing of Rifampicin/Isoniazid/Pyrazinamide in Children With Tuberculosis

Estie Mermelstein, MSN, FNP-BC

November 19, 2021

Investigators conducted a study to determine the optimal fixed-dose combination of rifampicin/isoniazid/pyrazinamide in children with tuberculosis infection.

Influenza

Efficacy of a Cell-Based Quadrivalent Inactivated Influenza Vaccine (IIV4c) in Children, Adolescents

Estie Mermelstein, MSN, FNP-BC

November 15, 2021

Investigators conducted a study to assess the efficacy of a cell-based quadrivalent inactivated influenza vaccine (IIV4c) in preventing influenza virus infection in adolescents and children.

General Medicine

Racial, Ethnic Disparities in COVID-19 Testing and Outcomes

Estie Mermelstein, MSN, FNP-BC

November 9, 2021

Researchers conducted a study to determine the effect of patient characteristics and racial/ethnic disparities on outcomes of SARS-CoV-2 infection.

General Pulmonology

Associations Found Between HIV Infection and Impaired Pulmonary Gas Exchange

Estie Mermelstein, MSN, FNP-BC

November 4, 2021

Investigators assessed the relationship between HIV infection and impaired pulmonary gas exchange, as well as the influence HIV has on the diffusing capacity of the lungs for carbon monoxide in patients with and without comorbid chronic obstructive pulmonary disease.

Pneumonia

Safety, Tolerability, Immunogenicity of the Novel Pneumococcal Conjugate Vaccine V114 in Patients at Risk for Pneumococcal Disease

Estie Mermelstein, MSN, FNP-BC

October 7, 2021

Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.

Next post in Pneumonia